Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Mitogen-activated protein kinase (MAPK) >  p38 MAPK inhibitor >  Losmapimod (GW856553X)

Losmapimod (GW856553X)

Basic information Safety Supplier Related

Losmapimod (GW856553X) Basic information

Product Name:
Losmapimod (GW856553X)
Synonyms:
  • 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
  • GW-856553
  • GSK-AHAB
  • GW 856553X
  • LosMapiMod
  • LosMapiMod,GW-856553
  • Losmapimod (GW856553X)
  • 3-Pyridinecarboxamide, 6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-
CAS:
585543-15-3
MF:
C22H26FN3O2
MW:
383.46
Product Categories:
  • Inhibitors
Mol File:
585543-15-3.mol
More
Less

Losmapimod (GW856553X) Chemical Properties

Boiling point:
529.4±50.0 °C(Predicted)
Density 
1.20±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
insoluble in EtOH; insoluble in H2O; ≥19.15 mg/mL in DMSO
form 
solid
pka
7.75±0.46(Predicted)
color 
White to off-white
More
Less

Safety Information

HS Code 
2933399990
More
Less

Losmapimod (GW856553X) Usage And Synthesis

Description

GW 856553X is a dual inhibitor of p38α and p38β MAPK (Kis = 0.0079 and 0.025 μM, respectively, in cell-free assays). It is selective for p38α and p38β MAPK over p38γ and p38δ MAPK when used at a concentration of 10 μM. GW 856553X inhibits LPS-induced TNF-α production in isolated rat and human peripheral blood mononuclear cells (PBMCs; IC50s = 0.6 and 0.13 μM, respectively). It decreases disease severity in a mouse model of collagen-induced arthritis when administered at doses ranging from 0.8 to 20 mg/kg. GW 856553X (1.2 and 12 mg/kg) improves survival, normalizes blood pressure, and reduces increases in plasma levels of HDL, LDL, and triglycerides in spontaneously hypertensive stroke-prone rats fed a high-salt high-fat diet.

Uses

Losmapimod is a selective, potent, and orally active p38 MAPK inhibitor.

Definition

ChEBI: 6-[5-[(cyclopropylamino)-oxomethyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide is a phenylpyridine.

target

p38α

References

[1]. willette rn, eybye me, olzinski ar, et al. differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease. j pharmacol exp ther, 2009, 330(3): 964-970.
[2]. cheriyan j, webb aj, sarov-blat l, et al. inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia. circulation., 2011, 123(5): 515-523.
[3]. lomas da, lipson da, miller be, et al. an oral inhibitor of p38 map kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease. j clin pharmacol, 2012, 52(3): 416-424.

Losmapimod (GW856553X)Supplier

Tianjin Kailiqi Biotechnology Co., Ltd. Gold
Tel
15076683720
Email
klq@cw-bio.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 17702719238
Email
sales@sun-shinechem.com
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
meilunui@163.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com
More
Less

Losmapimod (GW856553X)(585543-15-3)Related Product Information